InvestorsHub Logo

MinnieM

12/07/17 4:46 PM

#206797 RE: williamssc #206795

Aspire made it possible for the company to purchase the Brilacidin platform in addition to running clinical trials. That purchase was brilliant.

Also, management isn't selling, unless they have a deal with a bp we aren't aware of yet.